NuVasive Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
2,650
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.1B
NuVasive General Information
Description
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Contact Information
Website
www.nuvasive.com(Operating Subsidiary)
Corporate Office
- 7475 Lusk Boulevard
- San Diego, CA 92121
- United States
Corporate Office
- 7475 Lusk Boulevard
- San Diego, CA 92121
- United States
NuVasive Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 01-Sep-2023 | $3.1B | Completed | Generating Revenue | ||
| 10. Secondary Transaction - Open Market | Completed | Profitable | ||||
| 9. Merger/Acquisition | 09-Feb-2019 | Cancelled | Profitable | |||
| 8. Convertible Debt | 04-Apr-2016 | Completed | Profitable | |||
| 7. PIPE | 01-Jul-2013 | Completed | Profitable | |||
| 6. IPO | 13-May-2004 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D1) | 01-Aug-2002 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 21-May-2001 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 04-Aug-2000 | $3M | $19.8M | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 01-Oct-1999 | $12.3M | $16.8M | Completed | Generating Revenue |
NuVasive Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 4,635,000 | $0.001000 | $0.22 | $2.75 | $2.75 | 1x | $2.75 | 11.8% |
| Series A | 4,750,000 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 12.03% |
NuVasive Comparisons
Industry
Financing
Details
NuVasive Competitors (40)
One of NuVasive’s 40 competitors is Orthofix International, a Formerly PE-Backed company based in Lewisville, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Atec Spine | Formerly PE-Backed | Carlsbad, CA | ||||
| Synaptive Medical | Venture Capital-Backed | Toronto, Canada | ||||
| SeaSpine Holdings | Corporate Backed or Acquired | Carlsbad, CA |
NuVasive Patents
NuVasive Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12185931-B2 | Surgical instruments, systems, and methods with optical sensors | Active | 22-Jan-2024 | ||
| EP-4458293-A1 | Adjustable implant | Pending | 03-May-2023 | ||
| US-20240366273-A1 | Adjustable implant | Pending | 03-May-2023 | ||
| US-20240358418-A1 | Flat plate mechanisms for bone lengthening | Pending | 25-Apr-2023 | ||
| EP-4454581-A1 | Flat plate mechanisms for bone lengthening | Pending | 25-Apr-2023 | A61B17/8023 |
NuVasive Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NuVasive Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chicago Growth Partners | PE/Buyout | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Enterprise Partners Venture Capital | Venture Capital | Minority | ||
| Integral Capital Partners | Growth/Expansion | Minority | ||
| Johnson & Johnson Innovation - JJDC | Corporate Venture Capital | Minority |
NuVasive Investments & Acquisitions (19)
NuVasive’s most recent deal was a Early Stage VC with FYR (Monitoring Equipment) for . The deal was made on 14-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| FYR (Monitoring Equipment) | 14-Feb-2023 | Early Stage VC | Monitoring Equipment | ||
| Simplify Medical | 24-Feb-2021 | Merger/Acquisition | Therapeutic Devices | ||
| Progentix Orthobiology | 01-Jan-2018 | Merger/Acquisition | Other Devices and Supplies | ||
| Safe Passage Neuromonitoring | 01-Jan-2018 | Merger/Acquisition | Other Healthcare Services | ||
| Vertera Spine | 07-Sep-2017 | Merger/Acquisition | Therapeutic Devices |
NuVasive ESG
Risk Overview
Risk Rating
Updated December, 11, 2023
33.37 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
Healthcare
Industry
of 588
Rank
Percentile
Medical Devices
Subindustry
of 200
Rank
Percentile
NuVasive FAQs
-
When was NuVasive founded?
NuVasive was founded in 1997.
-
Where is NuVasive headquartered?
NuVasive is headquartered in San Diego, CA.
-
What is the size of NuVasive?
NuVasive has 2,650 total employees.
-
What industry is NuVasive in?
NuVasive’s primary industry is Surgical Devices.
-
Is NuVasive a private or public company?
NuVasive is a Private company.
-
What is the current valuation of NuVasive?
The current valuation of NuVasive is .
-
What is NuVasive’s current revenue?
The current revenue for NuVasive is .
-
How much funding has NuVasive raised over time?
NuVasive has raised $796M.
-
Who are NuVasive’s investors?
Chicago Growth Partners, Domain Associates, Enterprise Partners Venture Capital, Integral Capital Partners, and Johnson & Johnson Innovation - JJDC are 5 of 10 investors who have invested in NuVasive.
-
Who are NuVasive’s competitors?
Orthofix International, Globus Medical, Atec Spine, Synaptive Medical, and SeaSpine Holdings are some of the 40 competitors of NuVasive.
-
When was NuVasive acquired?
NuVasive was acquired on 01-Sep-2023.
-
Who acquired NuVasive?
NuVasive was acquired by Globus Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
